Total Payments
$1,648
2024 Payments
$791.54
Companies
14
Transactions
38
Medicare Patients
701
Medicare Billing
$49,453
Payment Breakdown by Category
Food & Beverage$1,215 (73.7%)
Education$432.96 (26.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,215 | 33 | 73.7% |
| Education | $432.96 | 5 | 26.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $318.56 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $259.92 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $172.99 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $153.74 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $116.59 | 4 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $105.40 | 1 | $0 (2023) |
| Karyopharm Therapeutics Inc. | $99.38 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $96.67 | 4 | $0 (2024) |
| PFIZER INC. | $83.99 | 1 | $0 (2023) |
| Eisai Inc. | $80.79 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $791.54 | 22 | Gilead Sciences, Inc. ($259.92) |
| 2023 | $583.92 | 13 | E.R. Squibb & Sons, L.L.C. ($219.71) |
| 2022 | $99.38 | 1 | Karyopharm Therapeutics Inc. ($99.38) |
| 2021 | $172.99 | 2 | Astellas Pharma US Inc ($172.99) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $110.19 | General |
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Oncology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Oncology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $98.85 | General |
| Category: Hematology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Solventum Corporation | ACTIV.A.C. (Device) | Food and Beverage | Cash or cash equivalent | $56.22 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.87 | General |
| 08/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONC | ||||||
| 08/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Education | In-kind items and services | $75.99 | General |
| Category: ONC | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.57 | General |
| 05/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Immunology | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Oncology | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.19 | General |
| 03/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.20 | General |
| 03/21/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $56.34 | General |
| Category: ONC | ||||||
| 01/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.77 | General |
| 12/06/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Hematology | ||||||
| 11/09/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $105.40 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/27/2023 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $120.81 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 115 | 135 | $39,710 | $10,310 |
| 2022 | 3 | 229 | 262 | $77,575 | $19,864 |
| 2021 | 7 | 357 | 435 | $68,773 | $19,280 |
Total Patients
701
Total Services
832
Medicare Billing
$49,453
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 85 | $25,160 | $6,477 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 20 | $6,960 | $2,245 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $7,590 | $1,588 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 96 | $28,416 | $7,195 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 51 | $17,748 | $4,999 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 26 | 34 | $11,424 | $3,339 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 46 | $11,132 | $2,477 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 35 | $8,855 | $1,853 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 106 | $31,376 | $8,588 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 64 | $16,192 | $3,624 | 22.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 26 | $9,048 | $3,058 | 33.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 22 | $5,257 | $1,485 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 22 | 24 | $3,651 | $1,020 | 27.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 59 | 77 | $1,771 | $770.88 | 43.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 53 | 74 | $814.00 | $452.90 | 55.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 22 | 26 | $442.00 | $186.48 | 42.2% |
| 83735 | Magnesium level | Office | 2021 | 13 | 16 | $222.40 | $93.80 | 42.2% |
About Amanda Wehner
Amanda Wehner is a Family healthcare provider based in Kalamazoo, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1356709919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Wehner has received a total of $1,648 in payments from pharmaceutical and medical device companies, with $791.54 received in 2024. These payments were reported across 38 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,215).
As a Medicare-enrolled provider, Wehner has provided services to 701 Medicare beneficiaries, totaling 832 services with total Medicare billing of $49,453. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Kalamazoo, MI
- Active Since 02/10/2016
- Last Updated 02/10/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1356709919
Products in Payments
- REBLOZYL (Biological) $256.45
- Trodelvy (Drug) $232.32
- ZEPZELCA (Drug) $105.40
- XPOVIO (Drug) $99.38
- Pomalyst (Drug) $98.90
- KEYTRUDA (Biological) $96.67
- XTANDI (Drug) $83.99
- Fabhalta (Drug) $63.36
- ACTIV.A.C. (Device) $56.22
- Lenvima (Drug) $56.06
- KISQALI (Drug) $53.23
- JEMPERLI (Biological) $33.70
- Leqembi (Drug) $24.73
- IMFINZI (Biological) $22.74
- CALQUENCE (Drug) $20.81
- Kadcyla (Biological) $17.63
- OPDUALAG (Drug) $15.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Kalamazoo
Ian Steward, N.p, N.P
Family — Payments: $5,124
Family $5,124
Thomas Geigert, Fnp-C, FNP-C
Family — Payments: $5,025
Family $5,025
Leslie Story, Np-C, NP-C
Family — Payments: $4,550
Family $4,550
Julie Tucker, Fnp, FNP
Family — Payments: $3,527
Family $3,527
Mrs. Elizabeth Doorn, Fnp-Bc, FNP-BC
Family — Payments: $2,325
Family $2,325
Heather Simon, Fnp-C, FNP-C
Family — Payments: $2,086
Family $2,086